Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA)

Significant short term risk with Iran nuke crisis, but short of Israel's destruction, any dip below $40 should be a great buying opportunity due to leadership in generic drugs.

everyone needs drugs! health care reform will require more generics

Generic drugs should continue to be a growth industry.

valuemoney liked it.

patent cliff.

More old people=more drugs. Leader in generics

Check out my thumbs-up CAPScall here:
http://www.fool.com/investing/general/2012/01/11/fear-2012-youre-not-alone.aspx

best of breed

This equity looks extremely cheap on paper.

TEVA seems to have hit bottom or near bottom. They have recently replaced a poor-performing CEO with a pharmaceutical industry veteran with a good track record. Should be much more upside than downside in the next 5 years with this one.

Teva's stock buyback coupled with higher expected earnings in 2012 plus a low PE will send the stock higher. Becuase it deals in generics it isn't affected negatively by the 2012-2013 patent cliff but is actually benifited by it. Everyone who needs their generics will continue to buy them becuase you can't live without your medication, its a defensive stock with growth prospects and a high dividend. Plus it is emerging into some new and interesting markets, and is aggresively pursuing 3rd world markets.

low debt, per M* solid competitive advantages

12/13

Uh-oh, looks like a just stumbled onto a cash cow with growing dividends and solid balance sheet. I'll hop in below Babo, Ultralong, and translator, sure! The water's just fine.

Wish this one wasn't in Israel - I don't like paying taxes on dividends, but hey, a growth story trading like a value story isn't to be ignored.

Also, if the you-know-what ever hits the fan in Middle East, Israel looks a tad sketchy. But for now, Fool on!

I have learned more from TEVA than any other stock in my young portfolio. I first bought shares based on headlines (the day after the health care bill was passed when TEVA hit its all-time high), sold when it dropped, then bought again as it got into the low 50s. Sold when it got lower. Then finally bought more in the mid/high 30s when I realized the numbers really were right and the stock was getting beaten up too much. I don't think it will outperform in the near-term but will several years out.

check out Perrigo then look at Teva's numbers. Why is Teva trading for so much less?

This is a "Giant Tortoise Stock." Like a giant tortoise, It may be big and slow, but it has a hard shell (economic moat), can swim far (enter into new and emerging markets and industries), and live long.

Technical Monthly

Teva is a fantastic company that has been beaten down the past few months due to macro issues. It takes advantage of the patent expirations of pharma giants such as Merck, Pfizer, Bristol Meyers Squibb, etc. It is the biggest generic drug maker and appeals to the masses as an affordable avenue of purchase.
The management team is fantastic and well run. Dr. Philip Frost is a key player on the board and has much experience on his side.